Center-Authored Papers

Filters: Author is Berry, Donald A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
Demichele A, Yee D, Berry DA, Albain KS, Benz CC, Boughey J, Buxton M, Chia SK, Chien AJ, Chui SY et al..  2015.  The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Venook AP, Arcila ME, Benson AB, Berry DA, Camidge DR, Carlson RW, Choueiri TK, Guild V, Kalemkerian GP, Kurzrock R et al..  2014.  NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(11):1629-49. Abstract
C
Levin VA, Tonge PJ, Gallo JM, Birtwistle MR, Dar AC, Iavarone A, Paddison PJ, Heffron TP, Elmquist WF, Lachowicz JE et al..  2015.  CNS Anticancer Drug Discovery and Development Conference White Paper.. Neuro-oncology. 17 Suppl 6:vi1-26. Abstract
A
Berry DA, Zhou S, Higley H, Mukundan L, Fu S, Reaman GH, Wood BL, Kelloff GJ, Jessup MJ, Radich JP.  2017.  Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.. JAMA oncology. :e170580. Abstract
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP et al..  2009.  Adjuvant chemotherapy in older women with early-stage breast cancer.. The New England journal of medicine. 360(20):2055-65. Abstract
Esserman LJ, Thompson IM, Reid B, Nelson P, Ransohoff DF, Welch GH, Hwang S, Berry DA, Kinzler KW, Black WC et al..  2014.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change.. The lancet oncology. 15(6):e234-42. Abstract